These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34992486)
21. Vaccination in neuromyelitis optica spectrum disorders: Friend or enemy? Cai H; Zhou R; Jiang F; Zeng Q; Yang H Mult Scler Relat Disord; 2022 Feb; 58():103394. PubMed ID: 35216775 [TBL] [Abstract][Full Text] [Related]
22. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study. Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797 [TBL] [Abstract][Full Text] [Related]
23. Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia. Algahtani H; Shirah B; Ibrahim B; Malik YA; Makkawi S Mult Scler Relat Disord; 2021 Jan; 47():102668. PubMed ID: 33307475 [TBL] [Abstract][Full Text] [Related]
24. Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis. Srikajon J; Siritho S; Ngamsombat C; Prayoonwiwat N; Chirapapaisan N; Mult Scler J Exp Transl Clin; 2018; 4(3):2055217318791196. PubMed ID: 30116549 [TBL] [Abstract][Full Text] [Related]
25. The Contribution of Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorders. Mateo J; Esteban O; Martínez M; Grzybowski A; Ascaso FJ Front Neurol; 2017; 8():493. PubMed ID: 29085325 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica. Neto SP; Alvarenga RM; Vasconcelos CC; Alvarenga MP; Pinto LC; Pinto VL Mult Scler; 2013 Feb; 19(2):173-8. PubMed ID: 22641300 [TBL] [Abstract][Full Text] [Related]
27. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review. Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871 [TBL] [Abstract][Full Text] [Related]
28. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort. Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910 [TBL] [Abstract][Full Text] [Related]
29. Spinal cord atrophy in neuromyelitis optica spectrum disorders. Wang Y; Wang Y; Tan S; Lu Z Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868 [TBL] [Abstract][Full Text] [Related]
30. Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study. Ashtari F; Ataei A; Kafieh R; Khodabandeh Z; Barzegar M; Raei M; Dehghani A; Mansurian M Mult Scler Relat Disord; 2021 Jan; 47():102625. PubMed ID: 33227631 [TBL] [Abstract][Full Text] [Related]
31. Association of Optic Neuritis with Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis in Korea. Kim H; Park KA; Oh SY; Min JH; Kim BJ Korean J Ophthalmol; 2019 Feb; 33(1):82-90. PubMed ID: 30746915 [TBL] [Abstract][Full Text] [Related]
32. Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials. Riederer I; Mühlau M; Hoshi MM; Zimmer C; Kleine JF J Neurol; 2019 Jan; 266(1):148-156. PubMed ID: 30446963 [TBL] [Abstract][Full Text] [Related]
33. Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Manogaran P; Hanson JV; Olbert ED; Egger C; Wicki C; Gerth-Kahlert C; Landau K; Schippling S Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854301 [TBL] [Abstract][Full Text] [Related]
34. The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder. Mehdipour-Dastjerdi R; Ashtari F; Shaygannejad V; Mansourian M; Safaei A Iran J Neurol; 2018 Apr; 17(2):58-63. PubMed ID: 30210729 [No Abstract] [Full Text] [Related]
35. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis. Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694 [TBL] [Abstract][Full Text] [Related]
36. Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis. Piedrabuena R; Bittar M Mult Scler Relat Disord; 2022 Jan; 57():103420. PubMed ID: 34906813 [TBL] [Abstract][Full Text] [Related]
37. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients. Watanabe A; Matsushita T; Doi H; Matsuoka T; Shigeto H; Isobe N; Kawano Y; Tobimatsu S; Kira J J Neurol Sci; 2009 Jun; 281(1-2):34-40. PubMed ID: 19339021 [TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea. Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965 [TBL] [Abstract][Full Text] [Related]